DSpace Repository

Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable >= Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

Show simple item record

dc.contributor.author Beksac, M
dc.contributor.author Seval, GC
dc.contributor.author Paydas, S
dc.contributor.author Tuglular, TF
dc.contributor.author Arslan, O
dc.contributor.author Goker, H
dc.contributor.author Kaynar, L
dc.contributor.author Altuntas, F
dc.contributor.author Atalay, F
dc.contributor.author Teke, HU
dc.contributor.author Bolaman, AZ
dc.contributor.author Pehlivan, M
dc.contributor.author Sonmez, M
dc.contributor.author Demir, AM
dc.contributor.author Topcuoglu, P
dc.contributor.author Yilmaz, M
dc.contributor.author Hacıoğlu Kabukçu, Sibel
dc.contributor.author Albayrak, M
dc.contributor.author Yurttas, NO
dc.contributor.author Salihoglu, A
dc.contributor.author Cakar, MK
dc.contributor.author Gurman, G
dc.date.accessioned 2020-06-08T13:41:35Z
dc.date.available 2020-06-08T13:41:35Z
dc.date.issued 2019
dc.identifier.issn 2152-2650
dc.identifier.uri http://hdl.handle.net/11499/32021
dc.language.iso English
dc.publisher CIG MEDIA GROUP, LP
dc.relation.isversionof 10.1016/j.clml.2019.09.402
dc.rights info:eu-repo/semantics/closedAccess
dc.subject elotuzumab; immunomodulatory drugs; Multiple myeloma
dc.subject C1 [Beksac, Meral; Seval, Guldane Cengiz; Arslan, Onder; Topcuoglu, Pervin; Gurman, Gunhan] Ankara Univ, Sch Med, Ankara, Turkey.
dc.subject [Paydas, Semra] Cukurova Univ, Sch Med, Adana, Turkey.
dc.subject [Tuglular, Tulin Firatli] Marmara Univ Hosp, Istanbul, Turkey.
dc.subject [Goker, Hakan] Hacettepe Univ, Sch Med, Ankara, Turkey.
dc.subject [Kaynar, Leylagul] Erciyes Univ, Sch Med, Kayseri, Turkey.
dc.subject [Altuntas, Fevzi] Yildirim Beyazit Univ, Sch Med, Ankara, Turkey.
dc.subject [Atalay, Figen] Baskent Univ, Istanbul Hlth Applicat & Res Ctr, Istanbul, Turkey.
dc.subject [Teke, Havva Uskudar] Osmangazi Univ, Sch Med, Eskisehir, Turkey.
dc.subject [Bolaman, Ali Zahit] Adnan Menderes Univ, Sch Med, Aydin, Turkey.
dc.subject [Pehlivan, Mustafa] Gaziantep Univ, Sch Med, Gaziantep, Turkey.
dc.subject [Sonmez, Mehmet] Karadeniz Tech Univ, Sch Med, Trabzon, Turkey.
dc.subject [Demir, Ahmet Muzaffer] Trakya Univ, Sch Med, Edirne, Turkey.
dc.subject [Yilmaz, Mehmet] Sanko Univ, Sch Med, Gaziantep, Turkey.
dc.subject [Kabukcu, Sibel Hacioglu] Pamukkale Univ, Sch Med, Denizli, Turkey.
dc.subject [Albayrak, Murat] Diskapi Yildirim Beyazit Educ & Res Hosp, Ankara, Turkey.
dc.subject [Yurttas, Nurgul Ozgur; Salihoglu, Ayse] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey.
dc.subject [Cakar, Merih Kizil] Dr Abdurrahman Yurtaslan Onkol Educ & Res Hosp, Ankara, Turkey.
dc.title Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable >= Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey
dc.type Meeting Abstract
dc.relation.journal CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
dc.identifier.volume 19
dc.identifier.issue 10
dc.identifier.startpage E242
dc.identifier.endpage E243
dc.relation.publicationCategory Uluslararası Hakemli Dergi
dc.identifier.index WOS


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record